Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
PLoS One ; 14(8): e0220898, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31419236

RESUMEN

Batroxobin, isolated from Bothrops moojeni, is a defibrinogenating agent used as a thrombin-like serine protease against fibrinogen for improving microcirculation. Here, we investigated whether, and if so, how batroxobin restores ischemic tissue injury in terms of anti-inflammatory effects. In an in vitro flow cytometry assay for human neutrophil extracellular traps (NETs), batroxobin (DF-521; Defibrase) inhibited human NETs induced by tumor necrosis factor-α (TNF-α) in the presence of human fibrinogen. Next, the effect of batroxobin was investigated by immunohistochemistry of the anterior tibial muscle (ATM) in an ischemic hindlimb model using C57BL/6J mice intraperitoneally injected with DF-521 versus the saline control. NETs and fibrinogen deposition in the ischemic ATM decreased in DF-521-treated mice on day 2 after ischemia. Meanwhile, reverse transcription-quantitative PCR assay of the ischemic ATM unveiled continuous downregulation in the expression of the genes; Tnf-α and nitric oxide synthase2 (Nos2) with hypoxia-inducible factor-1α (Hif-1α) and vascular endothelial growth factor-a (Vegf-a) from day 3 to day 7, but the upregulation of arginase-1 (Arg-1) and placental growth factor (Plgf) with myogenin (Myog) on day 7. Daily intraperitoneal DF-521 injection for the initial 7 days into mice with ischemic hindlimbs promoted angiogenesis and arteriogenesis on day 14. Moreover, DF-521 injection accelerated myofiber maturation after day 14. Laser doppler imaging analysis revealed that blood perfusion in DF-521-injected mice significantly improved on day 14 versus the saline control. Thus, DF-521 improves microcirculation by protecting NETs with tissue defibrinogenation, thereby protecting against severe ischemic tissue injury and accelerating vascular and skeletal muscular regeneration. To our knowledge, batroxobin might be the first clinically applicable NET inhibitor against ischemic diseases.


Asunto(s)
Batroxobina/uso terapéutico , Trampas Extracelulares/efectos de los fármacos , Fibrinolíticos/uso terapéutico , Isquemia/tratamiento farmacológico , Adulto , Animales , Antiinflamatorios/uso terapéutico , Células Cultivadas , Modelos Animales de Enfermedad , Trampas Extracelulares/inmunología , Miembro Posterior/irrigación sanguínea , Humanos , Inflamación/tratamiento farmacológico , Inflamación/inmunología , Isquemia/inmunología , Masculino , Ratones Endogámicos C57BL , Persona de Mediana Edad , Cicatrización de Heridas/efectos de los fármacos , Adulto Joven
2.
FEMS Microbiol Lett ; 364(11)2017 06 15.
Artículo en Inglés | MEDLINE | ID: mdl-28505287

RESUMEN

Some strains of lactic acid bacteria are reported to inhibit the growth of Helicobacter pylori and proposed to be useful to support so-called triple therapy for H. pylori. Although most strains must be alive to exert their anti-H. pylori activity, some lactobacilli strains are effective even when dead. One possible underlying mechanism of such an activity of non-living lactobacilli is reportedly co-aggregation with H. pylori. In this study, we found that a non-living heat-killed form of Lactobacillus johnsonii No.1088 (HK-LJ88) and also that of some other lactobacilli inhibited the growth of H. pylori in vitro. Furthermore, the number of H. pylori in the infected stomach of germ-free mice was significantly decreased by the repeated oral administration of HK-LJ88. Observation by scanning electron microscopy revealed that no co-aggregation had occurred between H. pylori and HK-LJ88; instead, deformations of H. pylori (e.g. disappearance of spiral, bending of cell body, coccoid formation, degradations, etc.) appeared after incubation for 24 h with HK-LJ88. These results suggest that HK-LJ88 inhibited H. pylori activity probably not by co-aggregation but by some unknown mechanism involving HK-LJ88's cell surface molecules and that even non-living lactobacilli are possibly useful to support H. pylori eradication therapy.


Asunto(s)
Antibiosis , Helicobacter pylori/crecimiento & desarrollo , Lactobacillus johnsonii/fisiología , Lactobacillus/fisiología , Animales , Modelos Animales de Enfermedad , Femenino , Infecciones por Helicobacter/terapia , Calor , Lactobacillus/clasificación , Masculino , Ratones , Ratones Endogámicos BALB C , Probióticos , Estómago/microbiología
3.
J Radiat Res ; 47(1): 49-59, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16571918

RESUMEN

The present article describes the series of incident primary ovarian tumors in the Life Span Study (LSS) cohort of the Radiation Effects Research Foundation, with particular emphasis on case ascertainment and characterization of histological features of the tumors. We identified 723 ovarian tumors (260 malignant, 463 benign) in 648 individuals of about 70,000 female LSS subjects; 71 cases had more than one ovarian tumor. We histologically confirmed 601 tumors (182 malignant, 419 benign tumors). The most frequent histological type was common epithelial tumor (90.7% for malignant and 59.7% for benign tumors). The distributions of ovarian tumors by histological type were similar to those from other studies. Among malignancies, the frequency of common epithelial types relative to other tumor types increased with radiation dose (p = 0.02). Among benign tumors, the relative frequency of sex-cord stromal tumors increased with radiation dose (p = 0.04). The women with mucinous cancer had better survival than those with serous cancers (p = 0.03). Within tumor types, there was no consistent pattern of survival by radiation dose. Variations in histological types of ovarian tumors in response to radiation dose, suggested by the case series data need to be followed up by population-based incidence analysis.


Asunto(s)
Neoplasias Inducidas por Radiación/mortalidad , Neoplasias Inducidas por Radiación/patología , Guerra Nuclear/estadística & datos numéricos , Neoplasias Ováricas/mortalidad , Neoplasias Ováricas/patología , Medición de Riesgo/métodos , Sobrevivientes/estadística & datos numéricos , Distribución por Edad , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Exposición a Riesgos Ambientales/estadística & datos numéricos , Femenino , Humanos , Incidencia , Japón/epidemiología , Persona de Mediana Edad , Neoplasias Inducidas por Radiación/clasificación , Neoplasias Ováricas/clasificación , Factores de Riesgo , Análisis de Supervivencia , Tasa de Supervivencia
4.
J Natl Cancer Inst ; 94(20): 1555-63, 2002 Oct 16.
Artículo en Inglés | MEDLINE | ID: mdl-12381708

RESUMEN

BACKGROUND: The risk of developing nervous system tumors following exposure to ionizing radiation is not well quantified. We characterized the incidence of nervous system tumors among atomic bomb survivors as a function of radiation dose. METHODS: Tumors of the nervous system and pituitary gland diagnosed between 1958 and 1995 among 80 160 atomic bomb survivors were ascertained using the Hiroshima and Nagasaki tumor registries, medical records, and death certificates. Pathologists reviewed slides and medical records to provide histologic diagnoses. Poisson regression analyses were used to characterize radiation effects on tumor incidence, which are expressed as excess relative risk per sievert (ERR(Sv)). All statistical tests were two-sided. RESULTS: A statistically significant dose-related excess of nervous system tumors was observed in the cohort (ERR(Sv) = 1.2, 95% confidence interval [CI] = 0.6 to 2.1). The highest ERR(Sv) was seen for schwannoma (4.5, 95% CI = 1.9 to 9.2). The risk for all other nervous system tumors as a group is also statistically significantly elevated (ERR(Sv) = 0.6, 95% CI = 0.1 to 1.3). Risk increases, although not statistically significant, were seen for meningiomas (ERR(Sv) = 0.6, 95% CI = -0.01 to 1.8), gliomas (ERR(Sv) = 0.6, 95% CI = -0.2 to 2.0), other nervous system tumors (ERR(Sv) = 0.5, 95% CI = <-0.2 to 2.2), and pituitary tumors (ERR(Sv) = 1.0, 95% CI = <-0.2 to 3.5). The dose-response relationships were linear. For nervous system tumors other than schwannoma, excess risks were higher for men than for women and for those exposed during childhood than for those exposed during adulthood. CONCLUSIONS: A statistically significant dose response was observed for all nervous system tumors combined and for schwannoma considered separately, indicating that exposure to even moderate doses (i.e., <1 Sv) of radiation is associated with an elevated incidence of nervous system tumors.


Asunto(s)
Neoplasias Inducidas por Radiación/epidemiología , Neoplasias del Sistema Nervioso/epidemiología , Neoplasias del Sistema Nervioso/etiología , Neoplasias Hipofisarias/epidemiología , Neoplasias Hipofisarias/etiología , Adulto , Anciano , Anciano de 80 o más Años , Relación Dosis-Respuesta en la Radiación , Femenino , Glioma/epidemiología , Glioma/etiología , Humanos , Incidencia , Japón/epidemiología , Modelos Lineales , Masculino , Meningioma/epidemiología , Meningioma/etiología , Persona de Mediana Edad , Neoplasias Inducidas por Radiación/etiología , Neurilemoma/epidemiología , Neurilemoma/etiología , Sistema de Registros , Riesgo , Sobrevivientes/estadística & datos numéricos
5.
Cancer Res ; 63(21): 7062-7, 2003 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-14612496

RESUMEN

Although 5-10% of gastric carcinoma (GC) cases worldwide are associated with EBV, a human herpesvirus, it is still not clear what the precise contribution of the virus is to the pathogenesis of EBV-positive GC. Here we report that EBV infection induces expression of insulin-like growth factor 1 (IGF-I) in the GC-derived EBV-negative cell line NU-GC-3 and that the secreted IGF-I acts as an autocrine growth factor. Transfection of individual EBV latent genes into NU-GC-3 cells revealed that the EBV-encoded small RNA (EBER) was responsible for IGF-I expression. Addition of recombinant IGF-I accelerated growth of NU-GC-3 cells, whereas growth of the EBV-converted NU-GC-3 cells was blocked by treatment with an anti-IGF-I antibody. These results suggest that IGF-I induced by EBER acts as an autocrine growth factor for EBV-positive GC. These findings seem to be operative in vivo, as EBV-positive GC biopsies consistently express IGF-I, whereas EBV-negative GC biopsies do not. EBER is invariably expressed in EBV-associated malignancies including GC. The present findings strongly suggest that EBV directly affects the pathogenesis of EBV-positive GC and underline the importance of RNA molecules on cell growth regulation.


Asunto(s)
Herpesvirus Humano 4/genética , ARN Viral/genética , Neoplasias Gástricas/patología , Neoplasias Gástricas/virología , División Celular/genética , Línea Celular Tumoral , Infecciones por Virus de Epstein-Barr/metabolismo , Infecciones por Virus de Epstein-Barr/virología , Humanos , Factor I del Crecimiento Similar a la Insulina/biosíntesis , Factor I del Crecimiento Similar a la Insulina/genética , Factor I del Crecimiento Similar a la Insulina/metabolismo , ARN Viral/biosíntesis , ARN Viral/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Neoplasias Gástricas/genética , Neoplasias Gástricas/metabolismo , Activación Transcripcional , Transfección
6.
Radiat Res ; 160(6): 707-17, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14640793

RESUMEN

An incidence survey of the Life Span Study (LSS) population found 1093 breast cancers among 1059 breast cancer cases diagnosed during 1950-1990. As in earlier breast cancer surveys of this population, a linear and statistically highly significant radiation dose response was found. In the analysis, particular attention was paid to modification of radiation dose response by age at exposure (e) and attained age (a). Dose-specific excess relative risk (ERR(1Sv)) decreased with increasing values of e and a. A linear dose-response model analysis, with e and a as exponential age modifiers, did not conclusively discriminate between the two variables as modifiers of dose response. A modified isotonic regression approach, requiring only that ERR(1Sv) be monotonic in age, provides a fresh perspective indicating that both e and a are important modifiers of dose response. Exposure before age 20 was associated with higher ERR(1Sv) compared to exposure at older ages, with no evidence of consistent variation by exposure age for ages under 20. ERR(1Sv) was observed to decline with increasing attained age, with by far the largest drop around age 35. Possible explanations for these observations are discussed, along with research approaches that might provide more information.


Asunto(s)
Neoplasias de la Mama/epidemiología , Neoplasias Inducidas por Radiación/epidemiología , Guerra Nuclear , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Relación Dosis-Respuesta en la Radiación , Femenino , Humanos , Incidencia , Japón , Persona de Mediana Edad , Factores de Tiempo
7.
Oncol Rep ; 12(3): 543-7, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15289835

RESUMEN

We examined 1,918 Japanese gastric cancer cases diagnosed during the period 1976-1995 to clarify histology-specific gender, age and tumor-location distributions of Epstein-Barr virus-associated gastric carcinoma (EBV-GC). EBV-GCs accounted for 4.5% and 6.1% of 1,088 intestinal-type and 830 diffuse-type gastric carcinomas, respectively. Both intestinal- and diffuse-type EBV-GCs showed male predominance, but the observed gender difference was statistically significant only in diffuse-type carcinomas (P<0.001). An age-dependent decrease of the EBV-GC proportion was observed in intestinal-type carcinomas (P=0.002), but not in diffuse-type carcinomas. In intestinal-type tumors, the estimated incidence of EBV-GCs reached its peak around age 70. Diffuse-type EBV-GCs appeared to have a much older peak incidence, if any. Both intestinal- and diffuse-type EBV-GCs were least prevalent in the stomach antrum. This study, examining the largest number of EBV-GCs in current literature, showed different patterns of age-dependence in intestinal- and diffuse-type EBV-GCs, suggesting that pathogenic pathways of EBV-GCs may be different in these 2 histological types.


Asunto(s)
Carcinoma/epidemiología , Carcinoma/virología , Infecciones por Virus de Epstein-Barr/metabolismo , Herpesvirus Humano 4/metabolismo , Neoplasias Gástricas/epidemiología , Neoplasias Gástricas/virología , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Diferenciación Celular , Femenino , Humanos , Hibridación in Situ , Mucosa Intestinal/metabolismo , Japón , Masculino , Persona de Mediana Edad , Factores Sexuales
8.
Arkh Patol ; 65(2): 35-9, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-15357246

RESUMEN

In order to determine the prevalence of the Epstein-Barr virus (EBV) infection in salivary gland lymphoepithelial carcinomas (LEC), we have collected 160 cases from Asian countries and Russia. All the cases examined by PCR for EBV DNA BamHI fragment and in-situ hybridization for EBER-1, EBV encoded small RNA, showed positivity for EBV infection in LEC cells, while no positive signals were found in any other salivary neoplasm examined. The incidence of LEC was highest in Guanzhou, followed by Shanghai and Chengdu and lowest in the northern parts of China, Seoul, Niigata, and Moscow. The mean age of the patients with LEC was 43.9 years with no sex predilection. The Chinese patients were of the Han race, only including minor races. There were ninety-five cases found with LEC in the parotid gland (75%), 20 in the submandibular gland (5%), and 28 in the minor salivary gland (20%). Histologically, the LECs were classified into two types: small nest type and large nest type. The latter type consisted of large-sized tumor cell nests and dense lymphocytic stromata and more frequently occurred in the minor salivary gland. The former consisted of small-sized tumor cell nests with fibrous and lymphocyte-depleted stromata, which were more frequently found in the parotid gland. The results indicated that EBV infection and certain geographic factors play important roles in the pathogenesis of the salivary LEC.


Asunto(s)
Carcinoma de Células Escamosas/epidemiología , Herpesvirus Humano 4 , Neoplasias de las Glándulas Salivales/epidemiología , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/virología , China , Herpesvirus Humano 4/genética , Humanos , Inmunohistoquímica , Hibridación in Situ , Japón , Corea (Geográfico) , Prevalencia , Federación de Rusia , Neoplasias de las Glándulas Salivales/patología , Neoplasias de las Glándulas Salivales/virología , Taiwán
9.
J Clin Exp Hematop ; 46(2): 67-71, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17142956

RESUMEN

We report here the rare case of a family predisposed to adult T-cell leukemia (ATL). Six of seven siblings developed ATL with ages of onset of 77, 48, 60, 64, 72, and 62 years old. Although virological tests for human T-lymphotropic virus type 1 were unavailable for two of the six patients, all were diagnosed with ATL based on their clinical, hematological, and histopathological features. Two of the six patients were tested for HLA haplotypes using fresh blood samples, and both were carriers of the HLA-A*26 allele known in the southern Japanese population to be susceptible to ATL. This series of genetic traits may help explain the familial predisposition to ATL.


Asunto(s)
Predisposición Genética a la Enfermedad , Antígenos HLA-A/genética , Leucemia-Linfoma de Células T del Adulto/genética , Anciano , Femenino , Infecciones por HTLV-I/complicaciones , Virus Linfotrópico T Tipo 1 Humano , Humanos , Leucemia-Linfoma de Células T del Adulto/patología , Masculino , Persona de Mediana Edad , Linaje
10.
Int J Cancer ; 117(3): 363-9, 2005 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-15900592

RESUMEN

Skin cancers, though rare in Japan, have reportedly been on the rise, but little else is known about epidemiologic features of different histologic types of skin cancer. The Life Span Study cohort, which consists of 93,700 atomic-bomb survivors, many of whom were exposed to negligibly low radiation doses, and 26,600 people not exposed to radiation, enables a population-based study of spontaneous as well as radiation-related cancer risk. Skin tumor incident cases diagnosed between 1958 and 1987 were ascertained by linkage to the Hiroshima and Nagasaki tumor registries augmented by searches of other data sources. Study pathologists reviewed tumor specimens and pathology reports and classified tumors using the World Health Organization classification scheme. They identified 274 primary incident skin cancers, of which 106 were basal cell carcinoma (BCC), 81 were squamous cell carcinoma (SCC), and 14 were malignant melanomas. Background incidence rates and radiation effects were assessed by Poisson regression models allowing for the effects of demographic and other covariates. BCC and SCC background incidence rates were both about 3 per 100,000 per year. BCCs were mainly on the head/neck (81%), whereas SCCs occurred most frequently on the arms/legs (45%) and head/neck (29%), consistent with the presumed role played by solar UV exposure in skin cancer. The BCC rates increased significantly between 1958 and 1987, whereas the SCC rates remained unchanged. The excess absolute risk of BCC per unit skin surface area related to atomic-bomb radiation exposure did not differ between UV-exposed and shielded parts of the body, suggesting the additivity of the radiation-related and background BCC risks.


Asunto(s)
Guerra Nuclear , Neoplasias Cutáneas/epidemiología , Neoplasias Cutáneas/patología , Adolescente , Adulto , Anciano , Estudios de Cohortes , Femenino , Humanos , Incidencia , Japón/epidemiología , Masculino , Persona de Mediana Edad , Neoplasias Inducidas por Radiación , Ceniza Radiactiva , Cintigrafía , Neoplasias Cutáneas/clasificación , Neoplasias Cutáneas/diagnóstico por imagen
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA